Naltrexone-hcl    (DrugBank: Naltrexone)

1 disease
IDDisease name (Link within this page)Number of trials
96Crohn disease1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,209 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00663117
(ClinicalTrials.gov)
September 200618/4/2008The Effects of Naltrexone on Active Crohn's DiseaseThe Effects of Naltrexone in Active Crohn's DiseaseInflammation;Crohn's DiseaseDrug: Naltrexone-HCl;Drug: PlaceboMilton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);The Broad FoundationCompleted18 Years75 YearsAll40Phase 2United States